Penumbra (PEN) Change in Receivables (2014 - 2026)
Penumbra (PEN) posted quarterly Change in Receivables of $8.0 million for Q2 2026, up 68.09% year-over-year from $4.8 million in Q2 2025, and up 245.04% quarter-over-quarter from -$5.5 million in Q1 2026.
Penumbra (PEN) Change in Receivables (2014 - 2026) Analysis & Trends
Penumbra (PEN) has reported Change in Receivables for 13 consecutive years, with $8.0 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Change in Receivables rose 68.09% year-over-year to $8.0 million; the TTM figure through Jun 2026 stood at $17.8 million (up 172.87% YoY), while the FY2025 annual figure was $19.5 million, up 173.37% from the prior year.
- Change in Receivables rose to $8.0 million in Q2 2026 per PEN's latest filing, from -$5.5 million in the prior quarter.
- Across five years, Change in Receivables topped out at $45.6 million in Q2 2022 and bottomed at -$25.4 million in Q3 2024.
- Historically, Change in Receivables has averaged $3.6 million across 5 years, with a median of $4.2 million in 2023.
- Annual changes were most pronounced in 2022 — Change in Receivables jumped 357.95% — and 2024, when it slumped 1301.43%.
- Penumbra's Change in Receivables stood at $12.5 million in 2022, then plunged by 150.74% to -$6.3 million in 2023, then soared by 49.05% to -$3.2 million in 2024, then surged by 311.14% to $6.8 million in 2025, then gained by 17.79% to $8.0 million in 2026.
- Business Quant data shows PEN's Change in Receivables at $8.0 million in Q2 2026, -$5.5 million in Q1 2026, and $6.8 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 386.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 177.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 46.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 10.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 172.10 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 79.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -90.00 Mn |
| 10 | Penumbra | 12.76 Bn | 12.10 Bn | 264.94 Mn | 8.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.04 Mn |
| Jun 30, 2026 | 8.04 Mn |
| Mar 31, 2026 | -5.54 Mn |
| Mar 31, 2026 | -5.54 Mn |
| Dec 31, 2025 | 6.82 Mn |
| Dec 31, 2025 | 6.82 Mn |
| Sep 30, 2025 | 8.45 Mn |
| Sep 30, 2025 | 8.45 Mn |
| Jun 30, 2025 | 4.78 Mn |
| Jun 30, 2025 | 4.78 Mn |
| Mar 31, 2025 | -543,000.00 |
| Mar 31, 2025 | -543,000.00 |
| Dec 31, 2024 | -3.23 Mn |
| Dec 31, 2024 | -3.23 Mn |
| Sep 30, 2024 | -25.39 Mn |
| Sep 30, 2024 | -25.39 Mn |
| Jun 30, 2024 | 10.49 Mn |
| Jun 30, 2024 | 10.49 Mn |
| Mar 31, 2024 | -8.46 Mn |
| Mar 31, 2024 | -8.46 Mn |